Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Landsec steps up capital recycling to reinvest in major retail

(Sharecast News) - Shares in Landsec were on the rise on Tuesday after the real estate group delivered a confident outlook, hailing the "significant" potential for income growth in the so-called major retail market. At a capital markets day for investors, the company said it will accelerate its capital recycling programme over the next 12-18 months, selling office assets to reinvest in shopping centres and retail parks.

The company, whose large-scale shopping centres include Bluewater in Kent, One New Change in London and Trinity in Leeds, has so far sold £644m of offices and low-returning retail assets since March.

"Given the superior income returns and attractive growth in income, [major retail] remains Landsec's highest conviction call, so in prioritising its capital allocation, the company does not plan to commit any meaningful capital to new development projects in the near term," Landsec said. "As a result, its committed development pipeline is expected to reduce to c. £0.2bn by mid-2026."

Since reporting its full-year results in May, the company said it has seen "good momentum" in income and profit growth, particularly in major retail where signed leases are 12% higher than estimated rental values, with relettings/renewals seeing rental uplifts of 13%. In London, signed leases over the year-to-date are 9% above ERV, with relettings/renewals 6% above previous passing rent.

Landsec said it remains on track to hit guidance of 3-4% in like-for-like net rental income and 2-4% growth in earnings per share this year. Looking further ahead, the company is targeting 4.5-7% CAGR in net rental income from its existing major retail portfolio by FY30.

Shares were 3.6% higher at 583.5p by 1440 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.